SS
LUCD icon

Sunbelt Securities’s Lucid Diagnostics LUCD Stock Holding History

Sunbelt Securities’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Buy
900,013
+516,014
+134% +$657K 0.07% 251
2025
Q4 		$419K Hold
383,999
– – 0.03% 447
2025
Q3 		$388K Buy
383,999
+300,000
+357% +$328K 0.03% 452
2025
Q2 		$68.8K Sell
83,999
-300,000
-78% -$387K 0.01% 866
2025
Q1 		$572K Buy
383,999
+300,000
+357% +$360K 0.05% 289
2024
Q4 		$67.2K Buy
+83,999
New +$74.1K 0.01% 872

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Sunbelt Securities's LUCD Position: Q1 2026 in Review

Sunbelt Securities increased its Lucid Diagnostics (LUCD) stake by 134% in Q1 2026, buying an estimated $657K and bringing the position to 900,013 shares worth $1.04M. The position accounts for 0.07% of the portfolio, ranked #251.

Sunbelt Securities first reported a position in LUCD in Q4 2024 and has held it in 6 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Sunbelt Securities held 900,013 shares of Lucid Diagnostics worth $1.04M as of Q1 2026.
  • Sunbelt Securities bought 516,014 Lucid Diagnostics shares in Q1 2026, an estimated $657K.
  • Lucid Diagnostics made up 0.07% of Sunbelt Securities's portfolio in Q1 2026, its #251 holding.
  • Sunbelt Securities first reported a position in Lucid Diagnostics in Q4 2024 and has held it in 6 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.